CGON
CG Oncology, Inc.
72.61
-0.03 (-0.04%)
52w low 37.01
80.97 high
81.0% of range
Financial Analysis
| Ratio | Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross Margin | -- | -- | 100.0% | 100.0% | -15.0% | |
| Operating Margin | -- | -18,453.4% | -27,180.9% | -10,067.3% | -4,722.1% | |
| EBITDA Margin | -- | -18,445.5% | -27,172.5% | -10,064.4% | -4,686.4% | |
| Net Margin | -- | -18,556.5% | -23,827.0% | -7,729.5% | -3,985.0% | |
| FCF Margin | -- | -15,611.5% | -22,391.7% | -6,931.3% | -3,279.2% | |
| Returns | ||||||
| Return on Equity | -- | -28.3% | -26.3% | -12.0% | -21.4% | |
| Return on Assets | -- | -24.0% | -24.4% | -11.7% | -20.3% | |
| Return on Inv Capital | -- | 44.8% | 35.6% | -12.4% | -19.9% | |
| Liquidity | ||||||
| Current Ratio | -- | 9.54x | 13.62x | 35.30x | 24.63x | |
| Quick Ratio | -- | 9.54x | 13.62x | 35.30x | 24.58x | |
| Cash Ratio | -- | 5.71x | 0.58x | 12.03x | 1.05x | |
| Leverage | ||||||
| Debt / Equity | -- | 0.13x | 0.00x | 0.00x | 0.01x | |
| Interest Coverage | -- | -35246.00x | -- | -- | -- | |
| Equity Multiplier | -- | 1.18x | 1.08x | 1.03x | 1.05x | |
| Efficiency | ||||||
| Asset Turnover | -- | 0.00x | 0.00x | 0.00x | 0.01x | |
| Inventory Turnover | -- | -- | -- | -- | 2.97x | |
| Op CF / Net Income | -- | 0.84x | 0.94x | 0.89x | 0.82x | |
| Investment | ||||||
| Capex / Revenue | -- | 7.3% | -- | 20.5% | 3.3% | |
| R&D / Revenue | -- | 15,198.4% | 22,427.5% | 7,208.3% | 2,887.2% | |
| SG&A / Revenue | -- | 3,355.0% | 4,853.4% | 2,959.0% | 1,820.0% | |
Revenue CAGR
+176.6%
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
+254.7%